Trial Profile
Phase I Study to Evaluate the Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in Patients With Chronic Myelogenous Leukemia.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Zileuton (Primary) ; Imatinib
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions
- 09 Jan 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 02 Aug 2011 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 09 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.